All,
Is there a minimum batch size for an approved product that is changing manufacturing sites? An approved topical product is being transferred to my firm and we will be submitting a CBE-30 supplement. Due to current equipment limitations our largest batch size is 57 kg. In the guidance: Guidance for Industry, ANDAs: Stability Testing of Drug Substances and Products, it states that the minimum batch size for topicals should be at least 100 kg or 10% of the commercial scale (whichever is greater). The guidance is for original ANDAs, but does this minimum apply for post-approval supplements as well? Will FDA refuse to receive this supplement because the batch size is too small?
Thank you for your help/advice.
Nathan
------------------------------
Nathan Johnston
Regulatory Affairs Senior Associate
Ei LLC
Kannapolis NC
------------------------------